Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults
- Conditions
- Dengue
- Interventions
- Biological: PlaceboBiological: TV005Biological: rDEN2∆30-7169
- First Posted Date
- 2014-12-17
- Last Posted Date
- 2017-02-01
- Target Recruit Count
- 48
- Registration Number
- NCT02317900
- Locations
- 🇺🇸
Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland, United States
🇺🇸University of Vermont Vaccine Testing Center, Burlington, Vermont, United States
Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali
- Conditions
- Lassa Virus Infection
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2019-12-12
- Target Recruit Count
- 601
- Registration Number
- NCT02311387
- Locations
- 🇲🇱
Malaria Research and Training Center, Bamako, Mali
A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2018-11-02
- Target Recruit Count
- 39
- Registration Number
- NCT02311413
- Locations
- 🇨🇦
St. Joseph's Healthcare, Hamilton, Ontario, Canada
Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults
- Conditions
- HIV Infections
- Interventions
- Biological: DNA Nat-B envBiological: Placebo for DNA Mosaic envBiological: DNA CON-S envBiological: Placebo for DNA Nat-B envBiological: Placebo for DNA CON-S envBiological: DNA Mosaic envBiological: Placebo for MVA-CMDRBiological: MVA-CMDR
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2023-04-24
- Target Recruit Count
- 105
- Registration Number
- NCT02296541
- Locations
- 🇺🇸
The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States
🇺🇸Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States
🇺🇸Fenway Health (FH) CRS, Boston, Massachusetts, United States
Tocilizumab (TCZ) in New-onset Type 1 Diabetes
- Conditions
- T1DMT1DType 1 Diabetes MellitusNew-onset Type 1 Diabetes Mellitus
- Interventions
- First Posted Date
- 2014-11-18
- Last Posted Date
- 2021-09-08
- Target Recruit Count
- 136
- Registration Number
- NCT02293837
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Benaroya Research Institute, Seattle, Washington, United States
🇺🇸Indiana University Health - Riley Hospital for Children, Indianapolis, Indiana, United States
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
- Conditions
- Influenza BInfluenza A
- Interventions
- Biological: Placebo for IVIGBiological: Intravenous hyperimmune immunoglobulin (IVIG)
- First Posted Date
- 2014-11-10
- Last Posted Date
- 2019-11-14
- Target Recruit Count
- 329
- Registration Number
- NCT02287467
- Locations
- 🇺🇸
University of Illinois, Chicago, Illinois, United States
🇺🇸Cooper University Hospital, Camden, New Jersey, United States
🇺🇸Cornell CRS, New York, New York, United States
Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide
- Conditions
- Chronic Granulomatous Disease
- Interventions
- Biological: Donor peripheral blood stem cells.Radiation: Total body 200cGy
- First Posted Date
- 2014-11-05
- Last Posted Date
- 2020-05-12
- Target Recruit Count
- 7
- Registration Number
- NCT02282904
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old
- Conditions
- Influenza A Virus, H7N9 Subtype
- Interventions
- Biological: H7N9 Anhui 2013/AA caBiological: Inactivated subvirion H7N9 vaccine
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2017-04-19
- Target Recruit Count
- 24
- Registration Number
- NCT02274545
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
B Cell Induction in Pediatric Lung Transplantation
- Conditions
- Lung Transplant
- Interventions
- Biological: Rituximab (Rituxan®)Biological: Placebo
- First Posted Date
- 2014-10-17
- Last Posted Date
- 2021-10-26
- Target Recruit Count
- 45
- Registration Number
- NCT02266888
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Human Immunity Against Staphylococcus Aureus Skin Infection
- Conditions
- Staphylococcus Aureus Skin Infection
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2021-03-30
- Target Recruit Count
- 49
- Registration Number
- NCT02262819
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States